CalciMedica Finalizes 1-for-5 Reverse Split to Regain Nasdaq Compliance
CALC sits 19% above its 52-week low of $0.461 on light trading volume (0.1× avg).
Summary
CalciMedica will execute a 1-for-5 reverse stock split effective August 28, with post-split trading starting August 31. The move reduces outstanding shares from about 34.5 million to 6.9 million and authorized shares from 500 million to 100 million. The company aims to lift its stock price above Nasdaq's $1 minimum bid requirement. This follows the proxy filed in July seeking shareholder approval, which was granted at the August 19 annual meeting. The reverse split is a compliance measure, not a fundamental change, but it materially alters the share structure and may affect liquidity and investor perception.
At the time of this announcement, CALC was trading at $0.55 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.1M. The 52-week trading range was $0.46 to $7.20. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.